Clinical Trial Update: STI571 ProspectIve RandomIzed Trial: SPIRIT [Phase 3]

View source ↗

Summary

Phase 3 randomized trial update for STI571 (imatinib) in chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• STI571 (imatinib)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Chronic Myeloid Leukemia | Phase 3 | Status: COMPLETED